Epigenetics in lung fibrosis: from pathobiology to treatment perspective
BA Helling, IV Yang - Current opinion in pulmonary medicine, 2015 - journals.lww.com
BA Helling, IV Yang
Current opinion in pulmonary medicine, 2015•journals.lww.comAlthough we are in very early stages of understanding the role of epigenetics in IPF, the
potential for the use of epigenetic marks as biomarkers and therapeutic targets is high and
discoveries made in this field will likely bring us closer to better prognosticating and treating
this fatal disease.
potential for the use of epigenetic marks as biomarkers and therapeutic targets is high and
discoveries made in this field will likely bring us closer to better prognosticating and treating
this fatal disease.
Summary
Although we are in very early stages of understanding the role of epigenetics in IPF, the potential for the use of epigenetic marks as biomarkers and therapeutic targets is high and discoveries made in this field will likely bring us closer to better prognosticating and treating this fatal disease.
Lippincott Williams & Wilkins